Poston Lab News & Events

News
Events

Why detecting the earliest biological signs of Parkinson’s disease is so crucial

Parkinson's disease is the second most common neurodegenerative disease, behind Alzheimer's disease, and affects nearly a million people in the United States. A new test can detect the biological signature of Parkinson’s disease before symptoms arise. Dr. Kathleen Poston explains why early diagnosis opens the door to better therapies.

Alzheimer’s and Parkinson’s biomarkers show promise for early diagnosis

New research supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute highlights significant strides researchers have made in developing biomarkers for early detection and monitoring of neurodegenerative diseases — including Alzheimer’s disease (AD), Parkinson's disease (PD) and Lewy Body Disease (LBD).

Redefining Parkinson's Disease

PODCAST: Join Kathleen Poston, MD, MS and Nicholas Weiler to learn about exciting advances in our ability to detect the brain pathology driving Parkinson's disease and related disorders much earlier, even before symptoms arise, and how this is opening doors for early intervention and — hopefully — prevention.

You, Your Loved One and Parkinson's Disease

What is the difference between an observational trial and an interventional trial? Why do people without Parkinson’s disease need to participate in Parkinson’s disease clinical trials? In an interview with the Michael J. Fox Foundation, Dr. Kathleen Poston answers these questions and more as she discusses what it means to part of clinical research. (Login required to view video) View video

Unlocking the Healing Power of You

Science is showing that how you feel isn’t just about what you eat, or do, or think. It’s about what you believe. Full National Geographic Story

The Poston Lab at Stanford is proud to be a founding partner in the International Parkinson’s disease ENIGMA Consortium!

Stanford-based Alzheimer’s Disease Research Center to be launched

A new Stanford-based center will receive nearly $7.3 million in funding over a five-year period to conduct interdisciplinary research on Alzheimer’s disease and related disorders. Visit the ADRC website

5th Grade Gratitude at Moving Day® 2016

We say out of the mouths of babes when a small child shows an adult’s wisdom and understanding of a situation. This phrase was fitting when Mrs. Kochar’s fifth grade class at Pioneer Elementary School in Union City wrote letters of gratitude to local leaders in neuroscience research and treatment of Parkinson’s disease.

Don't miss Kathleen Poston presenting "PD Heterogeneity" at the upcoming NINDS Advances in Therapeutics Development for Parkinson’s Disease Workshop.

April 20th, 2024: Parkinson’s Moving Day

Moving Day is an inspiring and empowering annual fundraising walk event that unites people around the country living with Parkinson’s disease, their care partners and loved ones to help beat Parkinson’s disease. Moving Day is more than just a walk. It’s a celebration of movement – proven to help manage Parkinson’s symptoms.

WHEN: April 20th at 9am PT

WHERE: Lake Cummings Regional Park in San Jose, CA 95125

Tweets by @pddoc